Bryce A. Harrison

1.1k total citations
19 papers, 790 citations indexed

About

Bryce A. Harrison is a scholar working on Molecular Biology, Organic Chemistry and Surgery. According to data from OpenAlex, Bryce A. Harrison has authored 19 papers receiving a total of 790 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Organic Chemistry and 5 papers in Surgery. Recurrent topics in Bryce A. Harrison's work include Chemical Synthesis and Analysis (5 papers), Diabetes Treatment and Management (5 papers) and Pancreatic function and diabetes (5 papers). Bryce A. Harrison is often cited by papers focused on Chemical Synthesis and Analysis (5 papers), Diabetes Treatment and Management (5 papers) and Pancreatic function and diabetes (5 papers). Bryce A. Harrison collaborates with scholars based in United States and China. Bryce A. Harrison's co-authors include Matthew G. Bursavich, Jean‐François Blain, Gregory L. Verdine, Erik J. Sorensen, Christoph W. Zapf, CARMEN DRAHL, Alan Wilson, David B. Rawlins, Faika Mseeh and Nicole C. Goodwin and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Cancer Research.

In The Last Decade

Bryce A. Harrison

19 papers receiving 766 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bryce A. Harrison United States	14	340	272	271	180	155	19	790
Philip A. Carpino United States	20	414 1.2×	365 1.3×	123 0.5×	153 0.8×	174 1.1×	42	1.1k
Jonathan B. Houze United States	14	476 1.4×	289 1.1×	328 1.2×	261 1.4×	98 0.6×	19	870
R. Kirk McPherson United States	18	815 2.4×	340 1.3×	272 1.0×	262 1.5×	54 0.3×	25	1.2k
Gee‐Hong Kuo United States	22	486 1.4×	540 2.0×	134 0.5×	106 0.6×	77 0.5×	46	1.0k
Richard Sulsky United States	12	640 1.9×	203 0.7×	94 0.3×	129 0.7×	135 0.9×	18	1.1k
Ralph Mosley United States	12	698 2.1×	172 0.6×	163 0.6×	143 0.8×	183 1.2×	15	1.2k
Dac M. Dinh United States	17	489 1.4×	144 0.5×	344 1.3×	370 2.1×	125 0.8×	29	1.1k
Eiji Kawanishi Japan	13	285 0.8×	311 1.1×	221 0.8×	131 0.7×	126 0.8×	20	664
Paul J. Dransfield United States	12	331 1.0×	244 0.9×	211 0.8×	162 0.9×	34 0.2×	13	573
Kennan Marsh United States	10	848 2.5×	551 2.0×	183 0.7×	366 2.0×	97 0.6×	17	1.5k

Countries citing papers authored by Bryce A. Harrison

Since Specialization

Citations

This map shows the geographic impact of Bryce A. Harrison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryce A. Harrison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryce A. Harrison more than expected).

Fields of papers citing papers by Bryce A. Harrison

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bryce A. Harrison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryce A. Harrison. The network helps show where Bryce A. Harrison may publish in the future.

Co-authorship network of co-authors of Bryce A. Harrison

This figure shows the co-authorship network connecting the top 25 collaborators of Bryce A. Harrison. A scholar is included among the top collaborators of Bryce A. Harrison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bryce A. Harrison. Bryce A. Harrison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

1.

Reszka-Blanco, Natalia, Vinod Yadav, Megan Krumpoch, et al.. (2021). Abstract 1559: Inhibition of integrin αvβ8 enhances immune checkpoint induced anti-tumor immunity by acting across immunologic synapse in syngeneic models of breast cancer. Cancer Research. 81(13_Supplement). 1559–1559. 1 indexed citations

2.

Bursavich, Matthew G., Bryce A. Harrison, Lori Hrdlicka, et al.. (2021). Discovery of the Oxadiazine FRM-024: A Potent CNS-Penetrant Gamma Secretase Modulator. Journal of Medicinal Chemistry. 64(19). 14426–14447. 8 indexed citations

3.

Sirois, Lauren E., et al.. (2018). Process Development for a Locally Acting SGLT1 Inhibitor, LX2761, Utilizing sp³–sp² Suzuki Coupling of a Benzyl Carbonate. Organic Process Research & Development. 23(1). 45–61. 3 indexed citations

4.

Powell, David R., Melinda Smith, Deon Doree, et al.. (2017). LX2761, a Sodium/Glucose Cotransporter 1 Inhibitor Restricted to the Intestine, Improves Glycemic Control in Mice. Journal of Pharmacology and Experimental Therapeutics. 362(1). 85–97. 25 indexed citations

5.

Bursavich, Matthew G., Bryce A. Harrison, Lori Hrdlicka, et al.. (2017). Design, Synthesis, and Evaluation of a Novel Series of Oxadiazine Gamma Secretase Modulators for Familial Alzheimer’s Disease. Journal of Medicinal Chemistry. 60(6). 2383–2400. 24 indexed citations

6.

Goodwin, Nicole C., Zhi‐Ming Ding, Bryce A. Harrison, et al.. (2017). Discovery of LX2761, a Sodium-Dependent Glucose Cotransporter 1 (SGLT1) Inhibitor Restricted to the Intestinal Lumen, for the Treatment of Diabetes. Journal of Medicinal Chemistry. 60(2). 710–721. 57 indexed citations

7.

Blain, Jean‐François, Matthew G. Bursavich, Lori Hrdlicka, et al.. (2016). Characterization of FRM-36143 as a new γ-secretase modulator for the potential treatment of familial Alzheimer’s disease. Alzheimer s Research & Therapy. 8(1). 34–34. 16 indexed citations

8.

Bursavich, Matthew G., Bryce A. Harrison, & Jean‐François Blain. (2016). Gamma Secretase Modulators: New Alzheimer’s Drugs on the Horizon?. Journal of Medicinal Chemistry. 59(16). 7389–7409. 104 indexed citations

9.

Veerman, Johan J. N., Matthew G. Bursavich, Rebecca Glen, et al.. (2016). Strategic and Tactical Approaches to the Synthesis of 5,6-Dihydro-[1,2,4]oxadiazines. Heterocycles. 92(12). 2166–2166. 10 indexed citations

10.

Powell, David R., Melinda Smith, Deon Doree, et al.. (2015). LP‐925219 maximizes urinary glucose excretion in mice by inhibiting both renal SGLT1 and SGLT2. Pharmacology Research & Perspectives. 3(2). e00129–e00129. 10 indexed citations

11.

Zambrowicz, Brian, J Freiman, Phil Brown, et al.. (2012). LX4211, a Dual SGLT1/SGLT2 Inhibitor, Improved Glycemic Control in Patients With Type 2 Diabetes in a Randomized, Placebo-Controlled Trial. Clinical Pharmacology & Therapeutics. 92(2). 158–169. 202 indexed citations

12.

Harrison, Bryce A., Alan Wilson, Brenda Gerhardt, et al.. (2009). Decreased Intraocular Pressure in Mice Following Either Pharmacological or Genetic Inhibition of ROCK. Journal of Ocular Pharmacology and Therapeutics. 25(3). 187–194. 36 indexed citations

13.

Goodwin, Nicole C., Ross Mabon, Bryce A. Harrison, et al.. (2009). Novel l-Xylose Derivatives as Selective Sodium-Dependent Glucose Cotransporter 2 (SGLT2) Inhibitors for the Treatment of Type 2 Diabetes. Journal of Medicinal Chemistry. 52(20). 6201–6204. 63 indexed citations

14.

Zapf, Christoph W., Bryce A. Harrison, CARMEN DRAHL, & Erik J. Sorensen. (2005). A Diels–Alder Macrocyclization Enables an Efficient Asymmetric Synthesis of the Antibacterial Natural Product Abyssomicin C. Angewandte Chemie International Edition. 44(40). 6533–6537. 91 indexed citations

15.

Zapf, Christoph W., Bryce A. Harrison, CARMEN DRAHL, & Erik J. Sorensen. (2005). A Diels–Alder Macrocyclization Enables an Efficient Asymmetric Synthesis of the Antibacterial Natural Product Abyssomicin C. Angewandte Chemie. 117(40). 6691–6695. 33 indexed citations

16.

Harrison, Bryce A., Gavril W. Pasternak, & Gregory L. Verdine. (2003). 2,6-Dimethyltyrosine Analogues of a Stereodiversified Ligand Library: Highly Potent, Selective, Non-Peptidic μ Opioid Receptor Agonists. Journal of Medicinal Chemistry. 46(5). 677–680. 16 indexed citations

17.

Shi, Zhang‐Jie, Bryce A. Harrison, & Gregory L. Verdine. (2003). Unpredictable Stereochemical Preferences for Mu Opioid Receptor Activity in an Exhaustively Stereodiversified Library of 1,4-Enediols. Organic Letters. 5(5). 633–636. 20 indexed citations

18.

Harrison, Bryce A., et al.. (2002). High-Affinity Mu Opioid Receptor Ligands Discovered by the Screening of an Exhaustively Stereodiversified Library of 1,5-Enediols. Journal of the American Chemical Society. 124(45). 13352–13353. 38 indexed citations

19.

Harrison, Bryce A. & Gregory L. Verdine. (2001). The Synthesis of an Exhaustively Stereodiversified Library of cis-1,5 Enediols by Silyl-Tethered Ring-Closing Metathesis. Organic Letters. 3(14). 2157–2159. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact